Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May 1;84(1):107-113.
doi: 10.1097/QAI.0000000000002313.

Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa

Helen Bell Gorrod  1 , Richard Court  2 , Michael Schomaker  3   4 , Gary Maartens  2 , Richard A Murphy  5   6   7
Affiliations

Increased Mortality With Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa

Helen Bell Gorrod et al. J Acquir Immune Defic Syndr. .

Abstract

Background: After failure of first-line antiretroviral therapy (ART) in the public sector, delayed or missed second-line ART switch is linked with poor outcomes in patients with advanced HIV.

Setting: We investigated delayed or missed second-line ART switch after confirmed virologic failure in the largest private sector HIV cohort in Africa.

Methods: We included HIV-infected adults with confirmed virologic failure after 6 months of nonnucleoside reverse-transcriptase inhibitor-based ART. We estimated the effect of timing of switch on the hazard of death using inverse probability of treatment weighting of marginal structural models. We adjusted for time-dependent confounding of CD4 count, viral load, and visit frequency.

Results: Five thousand seven hundred forty-eight patients (53% female) with confirmed virologic failure met inclusion criteria; the median age was 40 [interquartile range (IQR): 35-47], advanced HIV was present in 48% and the prior duration of nonnucleoside reverse-transcriptase inhibitor-based ART was 1083 days (IQR: 665-1770). Median time to confirmation of virologic failure and to second-line switch was 196 (IQR: 136-316) and 220 days (IQR: 65-542), respectively. Switching to second-line ART after confirmed failure compared with remaining on first-line ART reduced risk of subsequent death [adjusted hazard ratio: 0.47 (95% confidence interval: 0.36 to 0.63)]. Compared with patients who experienced delayed switch, those switched immediately had a lower risk of death, regardless of CD4 cell count.

Conclusions: Delayed or missed switch to second-line ART after confirmed first-line ART failure is common in the South African private sector and associated with mortality. Novel interventions to minimize switch delay should be tested and not limited to those with advanced disease at treatment failure.

PubMed Disclaimer

Conflict of interest statement

All authors declare no conflicts of interest

Figures

Figure 1.
Figure 1.. Hazard rations for death in patients with confirmed virologic failure by timing of second-line ART switch
*Adjusted for time-dependent confounding of CD4 count, VL, and visit frequency.
See this image and copyright information in PMC

References

    1. Estill J, Ford N, Salazar-Vizcaya L, et al. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: A mathematical modelling study. Lancet HIV. 2016. doi:10.1016/S2352-3018(16)00016-3. - DOI - PMC - PubMed
    1. Murphy RA, Court R, Maartens G, Sunpath H. Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps. AIDS Res Hum Retroviruses. 2017;33(12). doi:10.1089/aid.2017.0134. - DOI - PMC - PubMed
    1. Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010;24(June 2009):563–572. doi:10.1097/QAD.0b013e328333bfb7. - DOI - PubMed
    1. Sunpath H, Hatlen TJ, Naidu KK, et al. Targeting the third “90”: introducing the viral load champion. Public Heal Action. 2019. doi:10.5588/pha.18.0063. - DOI - PMC - PubMed
    1. Kaplan SR, Oosthuizen C, Stinson K, et al. Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study. PLoS Med. 2017. doi:10.1371/journal.pmed.1002407. - DOI - PMC - PubMed

Publication types

Substances